Graphene Oxide promotes embryonic stem cell differentiation to haematopoietic lineage

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Garcia Alegria, Eva ^a   Iluit, Maria ^b   Stefanska, Monika ^a   Silva, Claudio ^b   Heeg, Sebastian ^b   Kimber, Susan J ^c   Kouskoff, Valerie ^a   Lacaud, Georges ^a   Vijayaraghavan, Aravind ^b   Batta, Kiran ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Faculty of Life Sciences   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBLE COATED MATERIAL; GRAPHITE;

ANIMAL; BLOOD CELL; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; EMBRYONIC STEM CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN EMBRYONIC STEM CELL; MOUSE; MOUSE EMBRYONIC STEM CELL;

ANIMALS; BLOOD CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; COATED MATERIALS, BIOCOMPATIBLE; EMBRYONIC STEM CELLS; GRAPHITE; HEMATOPOIETIC STEM CELLS; HUMAN EMBRYONIC STEM CELLS; HUMANS; MICE; MOUSE EMBRYONIC STEM CELLS; MYELOID CELLS;

EID: 84973100749     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep25917     Document Type: Article

References (60)

1. Thomas, E. D., Lochte, H. L. Jr., Lu, W. C. & Ferrebee, J. W. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N. Engl. J. Med. 257, 491-496, doi: 10.1056/NEJM195709122571102 (1957).
2. Blum, B. & Benvenisty, N. The tumorigenicity of human embryonic stem cells. Adv. Cancer Res. 100, 133-158, doi: 10.1016/S0065-230X(08)00005-5 (2008).
3. Sturgeon, C. M., Ditadi, A., Clarke, R. L. & Keller, G. Defining the path to hematopoietic stem cells. Nat. Biotechnol. 31, 416-418, doi: 10.1038/nbt.2571 (2013).
4. Vo, L. T. & Daley, G. Q. De novo generation of HSCs from somatic and pluripotent stem cell sources. Blood 125, 2641-2648, doi: 10.1182/blood-2014-10-570234 (2015).
5. Woods, N. B. et al. Brief report: efficient generation of hematopoietic precursors and progenitors from human pluripotent stem cell lines. Stem Cells 29, 1158-1164, doi: 10.1002/stem.657 (2011).
6. Feng, Q. et al. Scalable generation of universal platelets from human induced pluripotent stem cells. Stem Cell Reports 3, 817-831, doi: 10.1016/j.stemcr.2014.09.010 (2014).
7. Mountford, J. C. & Turner, M. In vitro production of red blood cells. Transfus. Apher. Sci. 45, 85-89, doi: 10.1016/j.transci.2011.06.007 (2011).
8. Choi, K., Kennedy, M., Kazarov, A., Papadimitriou, J. C. & Keller, G. A common precursor for hematopoietic and endothelial cells. Development 125, 725-732 (1998).
9. Kennedy, M. et al. A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature 386, 488-493, doi: 10.1038/386488a0 (1997).
10. Fehling, H. J. et al. Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 130, 4217-4227 (2003).
11. Huber, T. L., Kouskoff, V., Fehling, H. J., Palis, J. & Keller, G. Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature 432, 625-630, doi: 10.1038/nature03122 (2004).
12. Zovein, A. C. et al. Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell 3, 625-636 (2008).
13. Lancrin, C. et al. The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 457, 892-895, doi: 10.1038/nature07679 (2009).
14. Lancrin, C. et al. Blood cell generation from the hemangioblast. J. Mol. Med. (Berl.) 88, 167-172, doi: 10.1007/s00109-009-0554-0 (2010).
15. Boisset, J. C. et al. In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium. Nature 464, 116-120, doi: 10.1038/nature08764 (2010).
16. Costa, G., Kouskoff, V. & Lacaud, G. Origin of blood cells and HSC production in the embryo. Trends Immunol. 33, 215-223, doi: 10.1016/j.it.2012.01.012 (2012).
17. Slukvin, I. I. Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells. Blood 122, 4035-4046, doi: 10.1182/blood-2013-07-474825 (2013).
18. Pagliuca, F. W. et al. Generation of functional human pancreatic beta cells in vitro. Cell 159, 428-439, doi: 10.1016/j.cell.2014.09.040 (2014).
19. Pearson, S., Cuvertino, S., Fleury, M., Lacaud, G. & Kouskoff, V. In vivo repopulating activity emerges at the onset of hematopoietic specification during embryonic stem cell differentiation. Stem Cell Reports 4, 431-444, doi: 10.1016/j.stemcr.2015.01.003 (2015).
20. Choi, J. S., Mahadik, B. P. & Harley, B. A. Engineering the hematopoietic stem cell niche: Frontiers in biomaterial science. Biotechnol J 10, 1529-1545, doi: 10.1002/biot.201400758 (2015).
21. Ireland, R. G. & Simmons, C. A. Human Pluripotent Stem Cell Mechanobiology: Manipulating the Biophysical Microenvironment for Regenerative Medicine and Tissue Engineering Applications. Stem Cells 33, 3187-3196, doi: 10.1002/stem.2105 (2015).
22. Bajaj, P., Schweller, R. M., Khademhosseini, A., West, J. L. & Bashir, R. 3D biofabrication strategies for tissue engineering and regenerative medicine. Annu Rev Biomed Eng 16, 247-276, doi: 10.1146/annurev-bioeng-071813-105155 (2014).
23. Bagley, J., Rosenzweig, M., Marks, D. F. & Pykett, M. J. Extended culture of multipotent hematopoietic progenitors without cytokine augmentation in a novel three-dimensional device. Exp. Hematol. 27, 496-504 (1999).
24. Banu, N., Rosenzweig, M., Kim, H., Bagley, J. & Pykett, M. Cytokine-Augmented culture of haematopoietic progenitor cells in a novel three-dimensional cell growth matrix. Cytokine 13, 349-358, doi: 10.1006/cyto.2001.0836 (2001).
25. Mantalaris, A., Keng, P., Bourne, P., Chang, A. Y. & Wu, J. H. Engineering a human bone marrow model: A case study on ex vivo erythropoiesis. Biotechnol. Prog. 14, 126-133, doi: 10.1021/bp970136+ (1998).
26. Liu, H. & Roy, K. Biomimetic three-dimensional cultures significantly increase hematopoietic differentiation efficacy of embryonic stem cells. Tissue Eng. 11, 319-330, doi: 10.1089/ten.2005.11.319 (2005).
27. Rahman, N., Purpura, K. A., Wylie, R. G., Zandstra, P. W. & Shoichet, M. S. The use of vascular endothelial growth factor functionalized agarose to guide pluripotent stem cell aggregates toward blood progenitor cells. Biomaterials 31, 8262-8270, doi: 10.1016/j.biomaterials.2010.07.040 (2010).
28. Park, S. et al. Biocompatible, robust free-standing paper composed of a TWEEN/graphene composite. Adv Mater 22, 1736-1740, doi: 10.1002/adma.200903611 (2010).
29. Agarwal, S. et al. Interfacing live cells with nanocarbon substrates. Langmuir 26, 2244-2247, doi: 10.1021/la9048743 (2010).
30. Sun, X. et al. Nano-Graphene Oxide for Cellular Imaging and Drug Delivery. Nano Res 1, 203-212, doi: 10.1007/s12274-008-8021-8 (2008).
31. Chen B. A.et al. Polyethylenimine-functionalized graphene oxide as an efficient gene delivery vector. J. Mater. Chem. 21, 7736-7741, doi: Doi 10.1039/C1jm10341e (2011).
32. Hong, J. et al. Graphene multilayers as gates for multi-week sequential release of proteins from surfaces. ACS Nano 6, 81-88, doi: 10.1021/nn202607r (2012).
33. Chen, G. Y., Pang, D. W., Hwang, S. M., Tuan, H. Y. & Hu, Y. C. A graphene-based platform for induced pluripotent stem cells culture and differentiation. Biomaterials 33, 418-427, doi: 10.1016/j.biomaterials.2011.09.071 (2012).
34. Lee, T. J. et al. Graphene enhances the cardiomyogenic differentiation of human embryonic stem cells. Biochem. Biophys. Res. Commun. 452, 174-180, doi: 10.1016/j.bbrc.2014.08.062 (2014).
35. Lv, M. et al. Effect of graphene oxide on undifferentiated and retinoic acid-differentiated SH-SY5Y cells line. Nanoscale 4, 3861-3866, doi: 10.1039/c2nr30407d (2012).
36. Luo, Y. et al. Enhanced Proliferation and Osteogenic Differentiation of Mesenchymal Stem Cells on Graphene Oxide-Incorporated Electrospun Poly(lactic-co-glycolic acid) Nanofibrous Mats. ACS Appl Mater Interfaces 7, 6331-6339, doi: 10.1021/acsami.5b00862 (2015).
37. Gu, Y. et al. Detection of circulating tumor cells in prostate cancer based on carboxylated graphene oxide modified light addressable potentiometric sensor. Biosens. Bioelectron. 66, 24-31, doi: 10.1016/j.bios.2014.10.070 (2015).
38. Fiorillo, M. et al. Graphene oxide selectively targets cancer stem cells, across multiple tumor types: Implications for non-Toxic cancer treatment, via "differentiation-based nano-Therapy". Oncotarget 6, 3553-3562 (2015).
39. Horvath, L. et al. Evaluation of the toxicity of graphene derivatives on cells of the lung luminal surface. Carbon 64, 45-60, doi: 10.1016/J.Carbon.2013.07.005 (2013).
40. Mikkola, H. K., Fujiwara, Y., Schlaeger, T. M., Traver, D. & Orkin, S. H. Expression of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo. Blood 101, 508-516, doi: 10.1182/blood-2002-06-1699 (2003).
41. Tavian, M. et al. [The hemangioblast, common precursor of endothelial and hematopoietic cells]. Transfus. Clin. Biol. 7, 238-241 (2000).
42. Jaffredo, T., Gautier, R., Eichmann, A. & Dieterlen-Lievre, F. Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny. Development 125, 4575-4583 (1998).
43. Sroczynska, P., Lancrin, C., Pearson, S., Kouskoff, V. & Lacaud, G. In vitro differentiation of mouse embryonic stem cells as a model of early hematopoietic development. Methods Mol. Biol. 538, 317-334, doi: 10.1007/978-1-59745-418-6-16 (2009).
44. Vodyanik, M. A., Bork, J. A., Thomson, J. A. & Slukvin, I. I. Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 105, 617-626, doi: 10.1182/blood-2004-04-1649 (2005).
45. Zhou, K. et al. Wnt and Notch signaling pathways selectively regulating hematopoiesis. Ann. Hematol. 89, 749-757, doi: 10.1007/s00277-010-0923-3 (2010).
46. Bressan, E. et al. Graphene based scaffolds effects on stem cells commitment. J. Transl. Med. 12, 296, doi: 10.1186/s12967-014-0296-9 (2014).
47. Wang, W. C. et al. Preparation of reduced graphene oxide/gelatin composite films with reinforced mechanical strength. Materials Research Bulletin 47, 2245-2251, doi: Doi 10.1016/J.Materresbull.2012.05.060 (2012)
48. Riddell, J. et al. Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors. Cell 157, 549-564, doi: 10.1016/j.cell.2014.04.006 (2014).
49. Sandler, V. M. et al. Reprogramming human endothelial cells to haematopoietic cells requires vascular induction. Nature 511, 312-318, doi: 10.1038/nature13547 (2014).
50. Lutolf, M. P. & Hubbell, J. A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 23, 47-55, doi: 10.1038/nbt1055 (2005).
51. Burnouf, T. et al. Blood-derived biomaterials and platelet growth factors in regenerative medicine. Blood Rev. 27, 77-89, doi: 10.1016/j.blre.2013.02.001 (2013).
52. Leisten, I. et al. 3D co-culture of hematopoietic stem and progenitor cells and mesenchymal stem cells in collagen scaffolds as a model of the hematopoietic niche. Biomaterials 33, 1736-1747, doi: 10.1016/j.biomaterials.2011.11.034 (2012).
53. Di Buduo, C. A. et al. Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies. Blood 125, 2254-2264, doi: 10.1182/blood-2014-08-595561 (2015).
54. Nayak, T. R. et al. Graphene for controlled and accelerated osteogenic differentiation of human mesenchymal stem cells. ACS Nano 5, 4670-4678, doi: 10.1021/nn200500h (2011).
55. Guo, W. et al. Construction of a 3D rGO-collagen hybrid scaffold for enhancement of the neural differentiation of mesenchymal stem cells. Nanoscale 8, 1897-1904, doi: 10.1039/c5nr06602f (2016).
56. Kaur, J. & Kumari, A. Exigency for fusion of graphene and carbon nanotube with biomaterials. Toxicol. Environ. Chem. 96, 699-721, doi: 10.1080/02772248.2014.978127 (2014).
57. Rourke, J. P. et al. The real graphene oxide revealed: stripping the oxidative debris from the graphene-like sheets. Angew. Chem. Int. Ed. Engl. 50, 3173-3177, doi: 10.1002/anie.201007520 (2011).
58. Camarasa, M. V. et al. Derivation of Man-1 and Man-2 research grade human embryonic stem cell lines. In Vitro Cell. Dev. Biol. Anim. 46, 386-394, doi: 10.1007/s11626-010-9291-5 (2010).
59. Kim, H. et al. Modulation of beta-catenin function maintains mouse epiblast stem cell and human embryonic stem cell self-renewal. Nat Commun 4, 2403, doi: 10.1038/ncomms3403 (2013).
60. Beers, J. et al. Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions. Nat. Protoc. 7, 2029-2040, doi: 10.1038/nprot.2012.130 (2012).